A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients
A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients
Sponsor: Central Institute of Mental Health, Mannheim
Terminated
Following the expiry of the original research grant, no follow-up financing could be provided to complete the study.
Other terminated trials from Central Institute of Mental Health, Mannheim
- Prodromal Schizophrenia · Phase PHASE3 · Jan 2021
- Pharmacokinetics, Bioavailability · Phase PHASE1 · Aug 2019
- Alcoholism · Phase EARLY_PHASE1 · May 2016
- Borderline Personality Disorder · Phase PHASE3 · Mar 2008
See all terminations from Central Institute of Mental Health, Mannheim
This PHASE2 trial investigates Schizophrenia and is currently terminated or withdrawn. Central Institute of Mental Health, Mannheim leads this study, which shows 13 recorded versions since 2015 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Jan 2025 — Sep 2025 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Unknown Status → Active Not Recruiting
▶ Show 8 earlier versions
-
May 2023 — Feb 2024 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
-
Nov 2022 — May 2023 [monthly]
Active Not Recruiting PHASE2
-
May 2021 — Nov 2022 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Active Not Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Mar 2018 [monthly]
Recruiting PHASE2
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central Institute of Mental Health, Mannheim
- Glostrup University Hospital, Copenhagen
- Heidelberg University
- Ludwig-Maximilians - University of Munich
- Martin-Luther-Universität Halle-Wittenberg
- Technical University of Munich
For direct contact, visit the study record on ClinicalTrials.gov .